+ currents to produce more-negative resting membrane potentials and thus less-excitable neurons; higher levels of ATP close K ATP channels and the resting membrane potential becomes more positive (4) . Ex vivo brain slice experiments performed in conditions that mimic KD hypoglycemic and ketotic states (i.e., with low extracellular glucose or in the presence of exogenous ketone bodies) found that K ATP channels were activated in these conditions (5, 6) . Interestingly, the authors of the current paper had previously identified another cellular energetics pathway that modulates K ATP currents in normal extracellular glucose concentrations and without exogenous ketone bodies. They found that that both unconditional deletion and phosphorylation site mutation of BCL-2 Agonist of Cell Death (BAD), a protein that modulates mitochondrial glucose metabolism in heathy cells (7)-as well performing its better-known role in mediating apoptosis in damaged cells-increased ketone body concentration and K ATP currents in vitro in the presence of typical electrophysiological extracellular solutions (8) . Moreover, in vivo, the loss of BAD function reduced pharmacologically evoked seizures, a protective effect that was lost in K ATP deletion mice (8) .
Although the previous BAD deletion/mutation experiments were performed without explicitly changing glucose or ketone concentrations, one might wonder if the unconditional manipulation of BAD (a protein involved in glucose metabolism in many tissues) might indirectly produce its effects on K ATP activity apart from the brain regions of interest. To test this possibility, the authors of the current paper virally delivered recombinant BAD into the hippocampi of BAD −/− mice. Hippocampal slice patch-clamp recordings of dentate granule neurons performed in the presence of typical glucose concentrations revealed that only neurons reconstituted with recombinant BAD and K ATP Channels Regulate Neuron Excitability and Epileptiform Activity. Brain metabolism can profoundly influence neuronal excitability. Mice with genetic deletion or alteration of Bad (BCL-2 agonist of cell death) exhibit altered brain-cell fuel metabolism, accompanied by resistance to acutely induced epileptic seizures; this seizure protection is mediated by ATP-sensitive potassium (K ATP ) channels. Here we investigated the effect of BAD manipulation on K ATP channel activity and excitability in acute brain slices. We found that BAD's influence on neuronal K ATP channels was cell-autonomous and directly affected dentate granule neuron (DGN) excitability. To investigate the role of neuronal K ATP channels in the anticonvulsant effects of BAD, we imaged calcium during picrotoxin-induced epileptiform activity in entorhinal-hippocampal slices. BAD knockout reduced epileptiform activity, and this effect was lost upon knockout or pharmacological inhibition of K ATP channels. Targeted BAD knockout in DGNs alone was sufficient for the antiseizure effect in slices, consistent with a 'dentate gate' function that is reinforced by increased K ATP channel activity.
A BAD Insight into a Molecular Mechanism of the Ketogenic Diet?
BAD (but not untransformed neurons) exhibited ATP-sensitive increases in K ATP activity, a result demonstrating regarding the effects of BAD deletion were cell-autonomous.
While it seems intuitive that the previous finding that unconditional BAD deletion reduces seizures resulted from increased K ATP currents, there was no direct evidence that the increased K ATP activity reduced neuronal excitability. Therefore, here, the authors directly tested the effects of BAD deletion on K ATP -dependent changes in neuronal firing in hippocampal slices from wild-type and BAD −/− mice. Importantly, they used perforated-patch recordings, a technique that makes electrical contact with the cell without altering its intracellular composition including its internal ATP concentration. Compared with wild-type neurons, BAD −/− neurons exhibited significantly fewer action potentials and were therefore less excitable. Pharmacological blockade of the K ATP channel eliminated the inhibitory effect in BAD −/− neurons but did not increase the excitability of wild-type neurons, results that suggest that the K ATP channel mediates the inhibitory effects if BAD deletion.
Finally, the investigators demonstrated that BAD −/− deletion would reduce seizure-like activity in hippocampal slices (specifically, picrotoxin-evoked spiking of calcium-associated GCaMP6 fluorescence), a result consistent with their previous in vivo experiment that showed resistance of BAD −/− mice to kainic acid-evoked seizures (8) . Perhaps more interesting, the current study also found that conditional deletion of BAD within the dentate gyrus was sufficient to produce the full inhibitory effect on the ex vivo seizure-like-activity. Therefore, BAD deletion-mediates upregulation of K ATP activity within a key node of an epilepsy network that may be sufficient to prevent seizures.
The results of this paper expanded the authors' prior work (8) and provided some important new information concerning the links among BAD, K ATP , and seizures. We now know that BAD deletion enhances K ATP currents within an individual neuron (as opposed to requiring an organism-or brain-wide effect), an important finding given that KD-or BAD-mediated changes in metabolic state could certainly have a multitude of global effects. This research also further clarified the anticonvulsant mechanism of BAD deletion by revealing the enhancement of K ATP currents and, at least for this seizure-like model, the sufficient localization of the effect to the dentate gyrus.
The demonstration that conditional deletion of BAD within the dentate gyrus sufficiently inhibits seizure-like activity in hippocampal slices suggested intriguing translational/therapeutic possibilities. Potentially, direct microinfusion of BAD or K ATP modulators to key epileptic networks nodes could prevent seizures without producing the side effects associated with systemic administration. However, because the KD is often prescribed for patients with extra-limbic seizures, including generalized or multifocal seizures in patients with epileptic encephalopathy syndromes (9), we need to first understand the effects of BAD and K ATP manipulations within these other seizure networks as well as the hippocampus.
Additional work also needs to be done to understand the mechanistic relationships among alterations of systemic metabolism, as occurs in the KD, BAD activity, and K ATP currents. The molecular underpinnings that mediate the effects of BAD on glucose homeostasis have been best-elucidated in hepatocytes and pancreatic β cells and these pathways are undoubtedly affected with the altered serum glucose concentrations that occur with the KD (7). Apart from the liver and pancreas, phosphorylation of Ser155 of neuronal BAD, the subject of this study, causes the neuronal mitochondria to catabolize glucose rather than ketone bodies (7, 8) . However, we do not know if systemic hypoglycemia or ketosis affects BAD in directing this switch in mitochondrial fuel. In addition, we also do not know if BAD signaling is needed for extracellular low-glucose or ketone bodies to enhance K ATP currents (5, 6) .
Determining the interactions between the KD and neuronal BAD will not only provide mechanistic insights into the coupling of neuronal energetics and excitability but will also be necessary to translate discoveries into potential therapies. Does neuronal BAD inhibition or direct K ATP enhancement contribute only a small portion to the total anti-seizure effects of the KD or closely match KD efficacy without requiring systemic hypoglycemia and ketosis? With the latter possibility, epilepsy patients may truly realize some of the benefits of the promised "ketogenic diet in a pill, " Moreover, countless medical students will have the "opportunity" to memorize yet one more pharmacological mechanism.
by Martin J. Gallagher, MD, PhD
